Clinical Trial Detail

NCT ID NCT01133678
Title Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Chicago
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab + Cisplatin + Paclitaxel

Everolimus

Age Groups: adult senior

No variant requirements are available.